The 2023 Society of Nuclear Medicine and Molecular Imaging (SNMMI) Mid-Winter and American College of Nuclear Medicine (ACNM) Annual Meeting provides physicians, technologists, pharmacists, laboratory professionals, and scientists with an in-depth view of the latest technologies and research in the field.

The meeting provides an in-depth review of advances in brain imaging, including neuroimaging applications in the nuclear medicine clinic, clinical molecular brain imaging, neuro-oncology imaging and therapy, molecular imaging of neuropsychiatric disorders, brain injury and traumatic encephalopathy syndrome, molecular brain imaging in dementia, quantification methods and AI-driven imaging of neurodegeneration, ATN framework applications to clinical trials, Parkinsonian syndromes, molecular imaging of acute rapidly progressing dementing disorders, and imaging of epilepsy.

The meeting also covers topics on AI in nuclear cardiology, correlative imaging in oncology focusing on PSMA-PET/MRI and Lu-177 PSMA therapy, PSMA RPT clinical trials and practice, clinical PET/MRI of the abdomen and pelvis, hybrid PET/CT cardiac imaging, pediatric renal scintigraphy for evaluation of urinary tract obstruction, molecular imaging of fever of unknown origin, basics of quantitative SPECT and PET, legal issues in clinical nuclear medicine, and emerging developments in theranostics

By attending the 2023 SNMMI Mid-Winter and ACNM Annual Meeting, participants will be able to:

• Examine and evaluate future directions in nuclear medicine and molecular imaging and therapy from a research and clinical perspective.
• Review standard, new and relevant advances in molecular imaging including applications in oncology, cardiology and neurology.
• Discuss new therapeutic and diagnostic agents that are impacting the practice of nuclear medicine and molecular imaging.
• Examine important regulatory information, procedures, and guidelines for imaging
• Describe the latest indications and applications of hybrid imaging and its impact on patient management.

In-Person Attendees can earn up to 22.0 CE Credits.
Virtual Attendees can earn up to 62.0 CE Credits starting January 26 through March 31, 2023.

CME Accreditation - AMA PRA Credits

• In-Person Attendance: SNMMI designates this Live Activity for a maximum of 22.0 AMA PRA Category 1 Credits™.

• Virtual Attendance: SNMMI designates this Enduring Material for a maximum of 62.0 AMA PRA Category 1 Credits™.

Physicians should claim only the credit commensurate with the extent of their participation in the activity. To receive CE credit, participants must complete the online evaluation available after the program.

Physician attendees will have the opportunity to earn SAM credits, provided they attend the entire session and complete the post-activity online evaluation. A final list of SAM sessions will be available on the Meeting App and at the Education Desk.

 VOICE Credit Statement

SNMMI-TS, through its Verification of Involvement In Continuing Education (VOICE) program, has approved the SNMMI 2023 SNMMI Mid-Winter and ACNM Annual Meeting for the following number of continuing education hours (CEHs):

VOICE-approved credit is recognized by most licensure states and by the NMTCB and ARRT as Category A+ credit. Partial credit is not awarded for partial attendance. A listing of the California Scope categories will be available on the Meeting App and at the Education Desk.

The Society of Nuclear Medicine and Molecular Imaging, Inc. (SNMMI) is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education.

Session UAN start with 0210-0000-23-001-L04-P and end with 0210-0000-23-035-L04-P. Topic designations and descriptions are: L01=Disease State Management/Drug Therapy; L04=General Pharmacy Topics; L05=Patient Safety. Sessions within this activity have been designated as knowledge-based and application-based CPE for Pharmacists. As per ACPE guidelines, attendance records will be uploaded to CPE Monitor within 60 days after the activity.

This meeting has applied to Commission on the Accreditation of Medical Physics Programs (CAMPEP) for approval of 62.0  Medical Physics Continuing Education Credit (MPCEC) hours.